Skip to main content
Terug
Watch Compare

Gain Therapeutics, Inc.

GANX
Nasdaq Manufacturing Chemicals
€ 1,80
▼ € 0,04 (-2,17%)
Marktkapitalisatie: 78,39 M
Prijs
€ 1,85
Marktkapitalisatie
78,39 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Koershistorie

Financiële Trends

Koersdoel Analisten

5 analisten
Buy
Huidig
€ 1,80
+322.2%
Koersdoel
€ 7,60
€ 5,00
€ 8,00
€ 10,00
Vooruitzicht
Forward K/W -2,89
Forward WPA -€ 0,62
Omzet Sch. 0,0

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 -€ 0,62
-€ 0,74 – -€ 0,47
 0,0 3
FY2026 -€ 0,61
-€ 0,79 – -€ 0,50
 0,0 4

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 -€ 0,15 -€ 0,11 +24,1%
Q32025 -€ 0,15 -€ 0,15 +2,2%
Q22025 -€ 0,17 -€ 0,19 -11,8%
Q12025 -€ 0,17 -€ 0,16 +4,0%

ETFs Holding This Stock

BRSIX BRSIX
0,06% weight

No fundamental snapshot available yet.

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — 55.180,0 55.180,0 140.108,0 164.994,0
Net Income -20,16 M -20,41 M -22,27 M -17,59 M -13,89 M
EPS (Diluted) -0,61 -0,89 -1,71 -1,48 -1,37
Gross Profit — — — — —
Operating Income -18,71 M -20,35 M -22,25 M -17,78 M -13,83 M
EBITDA — — — — —
R&D Expenses 10,21 M 10,79 M 11,52 M 8,38 M 7,16 M
SG&A Expenses — — — — —
D&A 94.046,0 84.071,0 83.579,0 64.168,0 15.484,0
Interest Expense — — 494.234,0 375.357,0 0,0
Income Tax 861.118,0 536.815,0 79.275,0 92.976,0 4.008,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 22,82 M 12,12 M 18,61 M 24,10 M 38,99 M
Total Liabilities 4,25 M 4,78 M 6,03 M 5,22 M 4,17 M
Shareholders' Equity 18,56 M 7,34 M 12,58 M 18,88 M 34,82 M
Total Debt 400.953,0 438.504,0 567.850,0 603.393,0 694.294,0
Cash & Equivalents 20,84 M 10,39 M 11,79 M 7,31 M 36,88 M
Current Assets 22,24 M 11,60 M 17,78 M 21,09 M 37,72 M
Current Liabilities 3,35 M 3,91 M 4,95 M 4,13 M 2,55 M